Marty Makary

The FDA's tobacco center recently published new guidelines that allow unauthorized e-cigarettes and nicotine pouches to enter the U.S. market before full regulatory review, bypassing standard scientif…

Cytokinetics’ aficamten met both primary and secondary endpoints in a Phase 3 trial for non-obstructive hypertrophic cardiomyopathy, positioning the drug for a potential regulatory filing and setting …